LONG MINI-FUTURE - MERCK & CO. Stock

Certificat

DE000VM6DQF4

Delayed Deutsche Boerse AG 14:02:31 2024-07-02 EDT
2.41 EUR -0.41% Intraday chart for LONG MINI-FUTURE - MERCK & CO.
Current month-4.37%
1 month+8.07%
Date Price Change
24-07-02 2.41 -0.41%
24-07-01 2.42 -3.97%
24-06-28 2.52 +0.80%
24-06-27 2.5 -13.49%
24-06-26 2.89 -2.36%

Delayed Quote Deutsche Boerse AG

Last update July 02, 2024 at 02:02 pm

More quotes

Static data

Product typeKnock-Out with Stop Loss
Buy / SellCALL
Underlying MERCK & CO., INC.
IssuerLogo Issuer Vontobel Vontobel
WKN VM6DQF
ISINDE000VM6DQF4
Date issued 2023-12-04
Strike 101.9 $
Maturity Unlimited
Parity 10 : 1
Emission price 0.51
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 3.01
Lowest since issue 0.47
Spread 0.08
Spread %3.16%

Company Profile

Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows: - sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.; - sale of vaccines (18%); - sale of animal health products (9.4%); - other (2.9%). Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
More about the company

Ratings for Merck & Co., Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Merck & Co., Inc.

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
127.7 USD
Average target price
142.7 USD
Spread / Average Target
+11.71%
Consensus